1. Introduction
===============

Bone recalcitrant nonunion and bone defects usually follow trauma, resection of a malignant tumor of the musculoskeletal system and osteomyelitis. Instead of amputation, which was used in the past, limb salvage surgeries, including non-vascularized or vascularized autografts and allografts,^\[[@R1]--[@R3]\]^ bone transport and replacement with prostheses,^\[[@R4],[@R5]\]^ are performed. Among the above methods, non-vascularized autogenous bone graft use is an important treatment strategy that has been performed for over a hundred years since 1911.^\[[@R6]\]^ In 1975, Taylor GI successfully used the free vascularized fibular graft for the reconstruction of skeletal defects.^\[[@R7]\]^ The fibula is a tubular bone that has a suitable length, geometrical shape and mechanical strength and is considered to be the best donor bone for large bone defects.^\[[@R8]\]^ Free vascularized fibular grafts achieve higher union rate than non-vascularized fibular grafts in the reconstruction of long bone defects.^\[[@R9]--[@R25]\]^

Currently, however, most studies have focused on the bony union rate or the functional outcome of the recipient site after the fibular graft, but few studies have reported on donor site complications and the ankle functional outcome of the donor site. Additionally, no studies have reported changes in hypertrophy of the grafts more than 10 years after the fibular graft surgery.

In this study, 10 patients with bone defects treated by non-vascularized fibular graft or free vascularized fibular graft were included. We intended to assess the clinical outcomes of graft union, functional outcome, hypertrophy of the graft bones and complications, which may be influenced by various factors from both non-vascularized and vascularized grafts.

2. Patients and methods
=======================

2.1. Patients
-------------

This study was a retrospective review and analysis approved by the Wuhan University institutional review boards. Between 1981 and 2015, 10 patients (mean age at operation 24.8 years, range 6 to 56 years, female/male = 4/6) had undergone surgery using a non-vascularized fibular graft or free vascularized fibular graft (vascularized/non-vascularized = 4/6) for reconstructions, and we excluded those with a follow-up period of less than 1 year; the average follow-up period was 6.8 years (range 1.0--26.0 years). The indication for surgery was a bone defect caused by a fracture (n = 2), osteomyelitis with a bony defect (n = 2) (Figs [1](#F1){ref-type="fig"}A and [3](#F3){ref-type="fig"}A), resection of fibrous dysplasia of bone (n = 3), or resection of a tumor (n = 3) (Fig. [2](#F2){ref-type="fig"}A). The recipient sites for the grafts included the femur (n = 3), radius (n = 2), tibia (n = 3), humerus (n = 1), and ilium (n = 1). Table [1](#T1){ref-type="table"} shows the patients' data.

###### 

Patient characteristics.
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2.2. Surgical techniques
------------------------

The fibulas were obtained using a posterior lateral approach, and at least the distal 1/4 length of the fibulas in all patients were retained to ensure the stability of the ankle. With the exception of 4 patients who previously had bone fractures with internal/external fixation or debridement of osteomyelitis, all patients had tumor resection or debridement and reconstruction at the same time. The graft used no fixation devices for stabilization of the ilium after resection of the tumor in 1 case. In 3 cases, the fibula grafts were wedged into the bone as an intercalary segment for reconstruction or only fixed with Kirschner wire. The reconstruction was stabilized with a plate in 6 cases. Overall, 10 patients underwent a reconstruction with a single fibular graft. Allograft or iliac bone grafts were used as a supplement in 6 patients. In 1 case, the medial formal condylus osteoperiosteal flap was pedicled with the descending genicular vessels at the same time that the fibular graft was placed to cover the bone defect and the graft^\[[@R26]\]^ (Fig. [1](#F1){ref-type="fig"}). None of the patients had undergone treatment with chemotherapy or radiotherapy. The mean length of the fibula was 9.9 cm (range 6--16).

![**A**: A 6-year-old boy was diagnosed with a massive bone defect in the right femur caused by osteomyelitis. **B:** Non-vascularized fibular graft (white arrows) harvested for construction. **C:** At 59 weeks after the surgery, the graft was consolidated. **D, E:** At 144 months after the surgery, significant hypertrophy of graft was achieved with excellent functional results, but there was a 22 cm discrepancy between his left and right lower extremities.](medi-97-e12605-g002){#F1}

2.3. Methods of follow-up and statistical analysis
--------------------------------------------------

The patients were followed systematically until bone healing was accomplished. Bone healing, hypertrophic changes of the graft and surgical complications (such as stress fracture and nonunion) were confirmed by plain radiographs or tomograms if necessary. Bony union of the graft was evaluated by the occurrence of bony trabeculae bridging on at least plain radiography at 1- to 3-month intervals. The hypertrophy of the graft was evaluated using diameters of recipient bone and the graft determined from the plain radiographs both immediately post-surgery and at the final follow-up according to the hypertrophy index of De Boer and Wood.^\[[@R27]\]^ The patients were evaluated functionally using the Musculoskeletal Tumor Society (MSTS) score^\[[@R28]\]^ at the final follow-up. The system of MSTS assigns numerical values (0--5) for each of 6 categories: pain, function and emotional acceptance in upper and lower extremities; supports, walking and gait in the lower extremity; hand positioning, dexterity and lifting ability in the upper extremity. Demographic information and a patient satisfaction component are included. Ankle mobility of the donor site was also assessed using the Kofoed ankle score system.^\[[@R29]\]^ The system includes 3 categories: pain, function and mobility, with a total points of 100. A score greater than 85 means excellent, between 75 and 85 means good and less than 75 means unacceptable.

The differences were determined using 1-way analysis of variance (ANOVA) and the chi-square test. Statistical analysis was performed using SPSS software (version 19.0; SPSS, Chicago, IL). A *P* value \< .05 indicated statistical significance.

3. Results
==========

Detailed data are presented in Table [2](#T2){ref-type="table"}.

###### 

Results.
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3.1. Bony union and hypertrophy
-------------------------------

Primary bony union was achieved in all 10 patients (100%) at both the proximal and distal ends of the graft segment. The average time to consolidation for bony healing was 26.8 weeks (range 16--59 weeks). There was no significant difference between vascularized grafts and non-vascularized grafts (*P* = .310), and the extra treatment with allograft or iliac bone graft did not influence bony union (*P* = .618). Moreover, the method of stabilization between the plate and other type of fixation had no significant effect on bony healing (*P* = .599). Graft hypertrophy was detected in 5 cases. In people who underwent reconstruction of the pelvis or for whom the graft was inlayed in the bone, accurate detection of graft hypertrophy was difficult to achieve by plain radiographs. Significant hypertrophy of more than 20% was detected in 3 cases, and the other 2 cases did not demonstrate significant changes (less than 20%). The type of the graft (*P* = .170) and the method of stabilization (*P* = .171) also had no influence on graft hypertrophy. Two patients had reconstructions of the lower extremity, and 3 patients had reconstructions of the upper limb, and there was a significant difference between them (*P* = .003).

3.2. Functional outcome
-----------------------

The average overall MSTS score at the last follow-up was 84% (range 53%--97%). Two patients had low MSTS scores: a boy (case 1) with a score of 53% who had his right femoral shaft replaced and who had a right lower extremity that was 22 cm shorter than the left lower extremity (Fig. [1](#F1){ref-type="fig"}E), and a girl (case 8) with a low score of 57% who underwent reconstruction of her femur and who later suffered a recurrence of fibrous dysplasia with fracture. The MSTS score of patients with non-vascularized fibular grafts (n = 6) was 80% (range 53% to 97%), whereas the MSTS score of patients with vascularized fibular grafts (n = 4) was 90% (range 80%--97%). Among the 10 patients, we found no significant difference in the MSTS scores between the vascularized fibular graft and non-vascularized fibular graft groups (*P* = .366).

3.3. Complications
------------------

No significant complications occurred in the intraoperative or immediate postoperative period. There was no problem with regard to the blood supply of the vascularized fibular graft shortly after the operation. Delayed postoperative complications, including fracture, occurred in 2 patients (20%). One patient had a stress fracture (Fig. [2](#F2){ref-type="fig"}D), and the other patient was diagnosed with a recurrence of fibrous dysplasia with fracture (case 8). Both fractures occurred after the graft union was achieved. Both cases were initially treated by internal fixation. Case 2 underwent a plate removal, iliac bone graft and fixation with a new plate (Fig. [2](#F2){ref-type="fig"}E). Case 8 underwent debridement, iliac bone graft, allograft and fixation with a plate. Both cases achieved bone healing after the surgery. A severe limb shortening occurred in 1 case (case 1) with a 22-cm discrepancy between his left and right lower extremities (Fig. [1](#F1){ref-type="fig"}D). This patient underwent a right femur lengthening with an external fixator 11 years after the reconstruction surgery.

![**A:** A 28-year-old man was diagnosed with a left proximal humeral giant cell tumor. **B:** After resection of the tumor, the defect in the left humerus was reconstructed with a free vascularized fibular head graft. **C:** At 21 weeks after the surgery, bony healing was obtained without significant hypertrophy. **D:** At 7 months after the operation, a stress fracture occurred at the level of the proximal extreme of the plate. **E:** The fracture was treated with plate removal, iliac bone graft and fixation with a new plate.](medi-97-e12605-g004){#F2}

Complications occurred at the donor site in 2 patients (case 7 and 10; 20%), as observed on radiographs of the donor site. Both patients had a mild valgus deformity of the ankle without ankle pain. The valgus deformity was 4.0 degrees in case 7 and 10.3 degrees in case 10. The distal fibula was 4.5 mm upward in case 7 and 3.2 mm in case 10. The 2 patients also had a length discrepancy between the 2 legs (Fig. [3](#F3){ref-type="fig"}F and 3G). At the time of operation, 5 patients were aged greater than or equal to 18 years, and 5 patients were aged less than 18 years. There was no significant difference between the 2 groups (*P* = .114). There were no painful neuromata, vascular injuries, long-lasting ankle pain or nerve injuries identified in any of the 10 patients. The mean Kofoed score was 96.8 (range 88--100), and overall, the 10 patients had excellent scores (\>85 points) and function of the ankle at the donor site.

![**A:** An 8-year-old boy was diagnosed with a bone defect in the right radius caused by osteomyelitis. **B:** Free vascularized fibular graft (white arrows) harvested for construction. **C:** At 20 weeks after the surgery, the graft was consolidated. **D, E:** Radiographs taken 216 months postoperatively show excellent bony healing and functional results. **F, G:** A significant valgus deformity at the donor site and a length discrepancy between the 2 legs occurred at the last follow-up.](medi-97-e12605-g005){#F3}

4. Discussion
=============

Reconstruction of bone defects caused by trauma, osteomyelitis, or tumor resection has always been a problem for orthopedic surgeons. There have been many recent reports of the successful application of vascularized fibular grafts,^\[[@R7],[@R9]--[@R15],[@R24]\]^ and non-vascularized grafts are rarely mentioned at present.

In a series of bone defects treated by vascularized fibular grafts, bone consolidation was reported to be obtained in 86% to 95% of cases at a mean of 3.6 to 12 months.^\[[@R8],[@R12],[@R13],[@R17],[@R30]\]^ Enneking et al^\[[@R20]\]^ found a primary union rate in 63% of non-vascularized fibular grafts within the first 12 months through clinical trials involving long bone reconstructions. In our study, the overall bony union rate was 100%, and the average time to consolidation for bony union was 26.8 weeks (range 16--59 weeks). There was no significant difference between the mean union time for vascularized fibular grafts (21.3 weeks) and non-vascularized fibular grafts (30.5 weeks) (*P* = .310). Han et al^\[[@R31]\]^ reported that reconstruction of a skeletal defect due to osteomyelitis using a vascularized bone graft might not have a satisfactory result. In our study, however, both patients with osteomyelitis achieved primary bony union, which suggested that a thorough debridement is necessary before a fibular graft is placed in patients with osteomyelitis.

Krieg et al found a significant difference in hypertrophy between vascularized and non-vascularized fibular grafts.^\[[@R18]\]^ It was mentioned in the literature^\[[@R12],[@R13],[@R17],[@R27]\]^ that hypertrophy of vascularized fibular grafts varies between 37% and 90%; by comparison, hypertrophy occurs in an average of 32% of non-vascularized grafts. In clinical research on vascularized fibular grafts, only 43% of vascularized fibular grafts achieved hypertrophy after 12 months,^\[[@R27]\]^ and extreme hypertrophy occurred between 2 and 3 years based on the literature.^\[[@R17],[@R27]\]^ Enneking et al^\[[@R20]\]^ found that 32% of non-vascularized fibular grafts demonstrated biological activity and hypertrophy. If there was a small diameter in contact at the recipient site, such as in the bones of the upper extremities, the diameter of the graft was unlikely to increase notably, which these authors did not take into consideration. In our study (Figs [1](#F1){ref-type="fig"}D, [2](#F2){ref-type="fig"}C and [3](#F3){ref-type="fig"}D), among the 5 grafts that could be detected, 4 of them increased in diameter. In the present study, we found a significant difference in hypertrophy (*P* = .003) when the host site was changed from the upper limbs to the lower limbs and it was reported earlier.^\[[@R12]\]^ Studies have suggested that hypertrophy was achieved earlier in grafts without internal fixation, such as screws or plates, and there was a greater degree of hypertrophy due to the higher mechanical load on the junctions.^\[[@R27]\]^ We also found that grafts fixed with a nail or a plate had a mean 128.3% change in hypertrophy compared to 5% for the grafts without nail or plate (*P* = .171). According to Soldado et al,^\[[@R32]--[@R34]\]^ an extra vascularized periosteal placement might accelerate the bone union due to a unique osteo- and angiogenic potential. In our study, case 1 underwent a non-vascularized fibular graft and a transplant of the medial formal condylus osteoperiosteal flap pedicled with the descending genicular vessels,^\[[@R26]\]^ which achieved a 200% hypertrophy, which is in keeping with these reports.

Among the 10 patients, we found no significant difference between the vascularized fibular graft and non-vascularized fibular graft groups in the MSTS scores (*P* =.366). However, using the MSTS score might have limitations, such as how the reconstructions were assessed. As with the population, the evaluation of function may be influenced by the ages of patients; therefore, the true function might not be reflected by the MSTS scores.

Non-vascularized fibular graft is a simpler, less expensive and a shorter procedure than the use of vascularized graft and allows remodeling of the fibula at the donor site.^\[[@R18]\]^ However, vascularized graft is a better choice when there is not a good cover with soft tissue and good blood supply or stabilization of the graft is difficult. Vascularized graft should be also used primarily in the lower leg and the forearm.

Stress fracture was 1 of the most prevalent delayed postoperative complications of the graft, occurring in between 15% and 40% of cases according to previous studies.^\[[@R13],[@R27],[@R30]\]^ In our study, stress fractures occurred in 10% of cases, and the patient who had his graft fractured underwent proximal humerus reconstruction after giant cell tumor resection using a free vascularized fibular head graft. The fracture occurred after the union of the graft junctions had been consolidated.

Donor site complications include painful neuromata, vascular injury, long-lasting ankle pain, nerve injury, and ankle instability. Complication rates for vascularized fibular graft are between 7% and 35%, as reported in the literature,^\[[@R13],[@R30],[@R35]--[@R37]\]^ whereas the rate for non-vascularized fibular grafts vary between 4% and 16%.^\[[@R18],[@R20],[@R38],[@R39]\]^ A common complication is valgus deformity of the ankle at the donor site in children, and it is reported to occur in 10% to 42% of cases according to the literature.^\[[@R13],[@R40],[@R41]\]^ In our study, this complication occurred in 2 of our patients (20%). Although we did not find a significant difference in age, the complication seems to occur more frequently in people aged less than 18 years old (40%) compared to those 18 years and older (*P* = .114). Nathan et al^\[[@R37]\]^ found that children were more likely to develop ankle instability than adults, and our study confirmed this finding. Excellent ankle functional outcomes were obtained at the donor site according to the Kofoed ankle score system, which supported that keeping at least the distal 1/4 of the fibula intact during the surgery is a reliable option to ensure ankle stability at the donor site. Although has a potential danger of arthrosis of the ankle joint, a primary synostosis of the distal tibia and fibula it might be advisable for children to prevent the valgus deformity of the ankle at the donor site.

An advantage of our study was the time of follow-up; 3 patients were followed for more than 10 years. Another advantage was the evaluation of the ankle at the donor site, which presented excellent results in all patients. A limitation in the present study was that the MSTS scores may not assess the exact function of the limbs; a score defined by quality of life could probably be used to increase the accuracy of functional evaluation. The most serious weakness and limitation was the number of patients, and the results may be more relevant as we increase the number of cases in the future.

5. Conclusions
==============

The application of fibular grafts in the reconstruction of bone defects caused by trauma, osteomyelitis or tumor resection represents an effective treatment option. Compared to vascularized fibular grafts, non-vascularized fibular grafts may need a longer time until union and should not be used when there is not a good cover with soft tissue and good blood supply or stabilization of the graft is difficult, but non-vascularized fibular graft is a simpler, less expensive and a shorter procedure than the use of vascularized graft. In terms of graft hypertrophy, similar hypertrophy can be obtained by both the abovementioned fibular grafts, but a greater increase in graft diameter might be achieved if the reconstruction is in the lower limbs. An extra transplant of vascularized periosteum might facilitate graft union and hypertrophy. In regards to functional outcome, patients had an average MSTS score of 84%, and there was no significant difference between non-vascularized and vascularized grafts. For donor site complications, a potential valgus deformity of the ankle should be considered before performing a fibular graft surgery on a child regardless of whether a vascularized or non-vascularized fibular graft is employed. Additionally, keeping at least the distal 1/4 of the fibula intact is a valid way to ensure ankle stability at the donor site, and children should be considered for prophylactic distal tibiofibular synostosis creation to prevent the valgus deformity of the ankle at the donor site.
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